Patents by Inventor Christopher F. Basler

Christopher F. Basler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VIRUS-LIKE PARTICLES AND USES THEREOF
    Publication number: 20220184200
    Abstract: Provided herein are virus-like particles and their uses for stimulating anti-pathogenic and anti-cancer immune responses.
    Type: Application
    Filed: March 20, 2020
    Publication date: June 16, 2022
    Applicant: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
    Inventors: Christopher F. BASLER, JoAnn M. TUFARIELLO, Lin WANG
  • Monoclonal antibodies to influenza H1N1 virus uses thereof
    Patent number: 8894997
    Abstract: The present invention is directed to particular monoclonal antibodies and fragments thereof that find use in the detection, prevention and treatment of influenza virus infections. In particular, these antibodies may neutralize or limit the replication of H1N1 influenza virus. Also disclosed are improved methods for producing such monoclonal antibodies.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: November 25, 2014
    Assignees: Vanderbilt University, Icahn School of Medicine at Mount Sinai
    Inventors: James E. Crowe, Christopher F. Basler
  • MONOCLONAL ANTIBODIES TO INFLUENZA H1N1 VIRUS USES THEREOF
    Publication number: 20120100142
    Abstract: The present invention is directed to particular monoclonal antibodies and fragments thereof that find use in the detection, prevention and treatment of influenza virus infections. In particular, these antibodies may neutralize or limit the replication of H1N1 influenza virus. Also disclosed are improved methods for producing such monoclonal antibodies.
    Type: Application
    Filed: April 30, 2010
    Publication date: April 26, 2012
    Inventors: James E. Crowe, JR., Jens C. Krause, Christopher F. Basler